Therapeutic targeting of TEAD transcription factors in cancer

AV Pobbati, R Kumar, BP Rubin, W Hong - Trends in Biochemical Sciences, 2023 - cell.com
The Hippo signaling pathway inhibits the activity of the oncogenic YAP (Yes-associated
protein)/TAZ (transcriptional co-activator with PDZ-binding motif)–TEAD (TEA/ATTS domain) …

Hippo Signaling at the Hallmarks of Cancer and Drug Resistance

R Kumar, W Hong - Cells, 2024 - mdpi.com
Originally identified in Drosophila melanogaster in 1995, the Hippo signaling pathway plays
a pivotal role in organ size control and tumor suppression by inhibiting proliferation and …

Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential

L Lv, X Zhou - MedComm, 2023 - Wiley Online Library
As highly conserved among diverse species, Hippo signaling pathway regulates various
biological processes, including development, cell proliferation, stem cell function, tissue …

TEAD4: A key regulator of tumor metastasis and chemoresistance-Mechanisms and therapeutic implications

M Liu, W Hu, X Meng, B Wang - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Cancer metastasis is a complex process influenced by various factors, including epithelial-
mesenchymal transition (EMT), tumor cell proliferation, tumor microenvironment, and cellular …

Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers

H Liang, Y Xu, J Zhao, M Chen, M Wang - Cancer Gene Therapy, 2024 - nature.com
Lung cancer is the primary contributor to cancer-related deaths globally, and non-small cell
lung cancer (NSCLC) constitutes around 85% of all lung cancer cases. Recently, the …

TEAD4 as an Oncogene and a Mitochondrial Modulator

SC Hsu, CY Lin, YY Lin, CC Collins… - Frontiers in Cell and …, 2022 - frontiersin.org
TEAD4 (TEA Domain Transcription Factor 4) is well recognized as the DNA-anchor protein
of YAP transcription complex, which is modulated by Hippo, a highly conserved pathway in …

AURKB/CDC37 complex promotes clear cell renal cell carcinoma progression via phosphorylating MYC and constituting an AURKB/E2F1-positive feedforward loop

F Li, X Wang, J Zhang, X **g, J Zhou, Q Jiang… - Cell Death & …, 2024 - nature.com
As the second most common malignant tumor in the urinary system, renal cell carcinoma
(RCC) is imperative to explore its early diagnostic markers and therapeutic targets …

[HTML][HTML] SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma

J Zhang, B Duan, F Li, X **g, R Li, S Cai… - … Journal of Biological …, 2024 - ncbi.nlm.nih.gov
Abstract SET domain containing 7 (SETD7), a member of histone methyltransferases, is
abnormally expressed in multiple tumor types. However, the biological function and …

Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell …

S Lv, L Tao, H Liao, Z Huang, Y Lu - Functional & Integrative Genomics, 2023 - Springer
Substantial progress has been made in cancer biology and treatment in recent years, but the
clinical outcome of patients with renal cell carcinoma (RCC) remains unsatisfactory. The …

High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinoma

W Guo, W Chen, J Zhang, M Li, H Huang, Q Wang… - BMC cancer, 2025 - Springer
Purpose Renal cell carcinoma (RCC) is a common malignancy, with patients frequently
diagnosed at an advanced stage due to the absence of sufficiently sensitive detection …